Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Breast Cancer Research and Treatment|May 29, 2007
Breast cancer in pregnancy: a literature reviewAndrea Molckovsky, Yolanda MadarnasBreast Cancer Research and Treatment|August 7, 2008
Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic reviewJennifer Flemming, Yolanda Madarnas, Jacob A FranekAdvances in Bioinformatics|March 29, 2012
Neutropenia Prediction Based on First-Cycle Blood Counts Using a FOS-3NN ClassifierElize A Shirdel, Michael J Korenberg, Yolanda MadarnasCancer Treatment Reviews|May 27, 2008
Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: a systematic reviewYolanda Madarnas, Maureen Trudeau, Jacob A Franek, et al.Breast (Edinburgh, Scotland)|June 1, 2013
Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapyDeb Feldman-Stewart, Yolanda Madarnas, Mihaela Mates, et al.Patient Education and Counseling|June 11, 2013
Information needs of post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapyDeb Feldman-Stewart, Yolanda Madarnas, Mihaela Mates, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort studyPamela J Goodwin, Marguerite Ennis, Kathleen I Pritchard, et al.Breast Cancer Research : BCR|September 19, 2014
A novel role for ezrin in breast cancer angio/lymphangiogenesisAbdi Ghaffari, Victoria Hoskin, Alvin Szeto, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 30, 2018
Novel prognostic and predictive microRNA targets for triple-negative breast cancerGulisa Turashvili, Elizabeth D Lightbody, Kathrin Tyryshkin, et al.Cancer Research Communications|March 16, 2023
Targeting the Ezrin Adaptor Protein Sensitizes Metastatic Breast Cancer Cells to Chemotherapy and Reduces Neoadjuvant Therapy-induced MetastasisVictoria Hoskin, Abdi Ghaffari, Brian J Laight, et al.Pageof 2